QURE
uniQure N.V.
Latest Form 4:Sale$952KbyKapusta Matthew C (CEO, Managing Director) · filed Jul 7, 2026
uniQure N.V. (QURE) has 37 SEC Form 4 filings (101 transaction rows) in the rolling window, disclosed by 12 distinct insiders. Most recent filing: Jul 7, 2026.
The most active filer is CEO, Managing Director Kapusta Matthew C with 9 filings. Insiders have net sold $20.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Matthew Kapusta
- Employees:221
- HQ:Amsterdam, NH, NL
- IPO:2014-02-05
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$32.4M
reported sales (SEC code S)
Unique Insiders
12
in the rolling window
Market Cap
$3.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CEO, Managing Director | Sale | 21,082 | $952K | Jul 7 | SEC ↗ | |
| Chief Medical Officer | Sale | 30,000 | $1.4M | Jul 2 | SEC ↗ | |
| Director | Sale | 21,167 | $983K | Jul 2 | SEC ↗ | |
| Chief Medical Officer | Sale | 1,434 | $67K | Jun 30 | SEC ↗ | |
| CEO, Managing Director | Sale | 6,696 | $335K | Jun 26 | SEC ↗ | |
| CEO, Managing Director | Sale | 28,716 | $1.4M | Jun 26 | SEC ↗ | |
Kapusta Matthew CFirst in 4 months | CEO, Managing Director | Sale | 164,429 | $7.3M | Jun 22 | SEC ↗ |
Kapusta Matthew CFirst in 4 months | CEO, Managing Director | Sale | 41,671 | $2.1M | Jun 22 | SEC ↗ |
| Director | Sale | 11,685 | $526K | Jun 22 | SEC ↗ | |
| Director | Sale | 5,295 | $225K | Jun 22 | SEC ↗ | |
Potts JeannetteFirst in 3 months | Chief Legal Officer | Sale | 5,237 | $145K | Jun 17 | SEC ↗ |
| Director | Sale | 10,000 | $279K | Jun 17 | SEC ↗ | |
O'Keefe KylieFirst filing | Chief Customer & Strat Officer | Sale | 15,936 | $431K | Jun 12 | SEC ↗ |
Meek David D.First filing | Director | Sale | 1,993 | $54K | Jun 12 | SEC ↗ |
Balachandran MadhavanFirst filing | Director | Sale | 1,993 | $54K | Jun 12 | SEC ↗ |
| Director | Sale | 1,993 | $54K | Jun 12 | SEC ↗ | |
Gut RobertFirst in 5 months | Director | Sale | 7,552 | $197K | Jun 12 | SEC ↗ |
Gut RobertFirst in 5 months | Director | Sale | 2,726 | $74K | Jun 12 | SEC ↗ |
Springhorn Jeremy P.First filing | Director | Sale | 1,993 | $54K | Jun 12 | SEC ↗ |
| Director | Sale | 1,993 | $54K | Jun 12 | SEC ↗ | |
Jacques Rachelle SuzanneFirst filing | Director | Sale | 1,993 | $54K | Jun 12 | SEC ↗ |
Kaye JackFirst in 5 months | Director | Sale | 2,645 | $79K | Jun 5 | SEC ↗ |
| Chief Medical Officer | Sale | 45,000 | $1.1M | May 12 | SEC ↗ | |
| Chief Financial Officer | Sale | 12,000 | $109K | Mar 6 | SEC ↗ | |
| Chief Medical Officer | Sale | 808 | $7K | Mar 6 | SEC ↗ | |
| Chief Legal Officer | Sale | 3,412 | $31K | Mar 6 | SEC ↗ | |
| CEO, Managing Director | Sale | 14,581 | $132K | Mar 6 | SEC ↗ | |
| CEO, Managing Director | Sale | 34,437 | $343K | Mar 4 | SEC ↗ | |
Potts JeannetteFirst filing | Chief Legal Officer | Sale | 8,578 | $85K | Mar 4 | SEC ↗ |
Abi-Saab WalidFirst filing | Chief Medical Officer | Sale | 1,660 | $17K | Mar 4 | SEC ↗ |
| Chief Financial Officer | Sale | 12,532 | $125K | Mar 4 | SEC ↗ | |
KLEMT CHRISTIANFirst in 5 months | Chief Financial Officer | Sale | 6,217 | $148K | Feb 27 | SEC ↗ |
Kapusta Matthew CFirst in 5 months | CEO, Managing Director | Sale | 12,378 | $295K | Feb 27 | SEC ↗ |
| Director | Sale | 25,613 | $630K | Jan 14 | SEC ↗ | |
| Director | Sale | 6,390 | $174K | Jan 12 | SEC ↗ | |
Gut RobertFirst filing | Director | Sale | 31,434 | $857K | Nov 10 | SEC ↗ |
Kaye JackFirst filing | Director | Sale | 38,810 | $1.2M | Nov 6 | SEC ↗ |
Kapusta Matthew CFirst filing | CEO, Managing Director | Sale | 226,316 | $9.4M | Sep 26 | SEC ↗ |
KLEMT CHRISTIANFirst filing | Chief Financial Officer | Sale | 3,000 | $120K | Sep 26 | SEC ↗ |
KLEMT CHRISTIANFirst filing | Chief Financial Officer | Sale | 15,000 | $825K | Sep 26 | SEC ↗ |
Related companies
uniQure N.V. is in the Healthcare sector.